BMY Bristol-Myers Squibb Company
$56.25
▼ 0.51%
54
Value
60
P/E15.80
67
P/B5.73
44
P/S2.37
59
EV/EBITDA10.87
68
Growth
42
Revenue Growth-0.2%
27
EPS Growth178.5%
55
FCF Growth-7.9%
43
Momentum
56
12-Month Return18.2%
60
3-Month Return-5.5%
51
1-Month Return-5.0%
44
RSI (14)33.45
50
50/200 MABullish
75
Profitability
60
ROE39.0%
59
ROA8.4%
52
Gross Margin68.7%
58
Operating Margin25.7%
57
Net Margin15.0%
49
FCF Yield10.4%
82
Risk
49
Beta0.26
35
60-Day Volatility25.4%
61
QScore Analysis